PCM
BOLD

Prelude Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Prelude Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,500
Closed -$209K – 2314
2019
Q4 		$209K Buy
+3,500
New +$131K 0.01% 844

Prelude Capital Management's BOLD Position: Q1 2020 in Review

Prelude Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 278,465 shares — an estimated $16.7M sold.

Prelude Capital Management first reported a position in BOLD in Q3 2017 and held it in 4 quarters. The position peaked at $16.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Prelude Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 278,465 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $16.7M.
  • Prelude Capital Management first reported a position in Audentes Therapeutics, Inc in Q3 2017 and held it in 4 quarters.
  • Prelude Capital Management's Audentes Therapeutics, Inc position peaked at $16.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.